Share This

Related Topics News -

     
 Title only   |   Print 
     
康諾亞-B:旗下鼻炎藥品獲國家藥監局受理上市許可申請

2024-04-30T  
康諾亞司普奇拜單抗III期臨床試驗達III期

2024-04-29T  
樂普生物治療晚期實體瘤藥物臨床試驗完成首例受試者首次給藥

2024-04-15T  
康諾亞-B附屬治療晚期實體瘤藥物首例受試者完成首次給藥

2024-04-12T  
《公司業績》康諾亞全年虧損擴至3.59億人民幣

2024-03-27T  
醫藥股普遍隨A股續升 來凱飆47% 藥明系續升10%-13%

2024-02-07T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.